Recent Posts
BTEC course expands to include ADCs, PEGylated therapeutics and more
Therapeutic proteins, the largest class of biopharmaceuticals, offer life-changing treatments such as enzyme replacement therapy, which can treat a variety of cancers and metabolic disorders....
AIM-Bio program continues to deliver results
As the AIM-Bio program enters its sixth year, we reflect on its success, driven by a partnership between the Technical University of Denmark (DTU) and...
Investing in talent: AIM-Bio’s impact on biotechnology
One of the significant outcomes of the AIM-Bio Program is the positive impact for students and the workforce in both North Carolina and Denmark. Since...
DTU collaborates with biotech leaders to shape lifelong learning program
The Technical University of Denmark (DTU) is advancing its biotech lifelong learning initiatives with guidance from its Biotech Lifelong Learning Advisory Board, which includes leaders from...
BTEC hosts 5th Annual AIM-Bio Symposium
BTEC hosted more than 80 participants at the 5th Annual AIM-Bio Biopharmaceutical Manufacturing Symposium, which was held on the NC State campus Nov. 18–19. Faculty,...
Building a skilled workforce: How AIM-Bio supports the EU’s biomanufacturing future
The European Union’s recent communication titled “Building the future with nature: Boosting Biotechnology and Biomanufacturing in the EU” outlines a strategic vision to enhance the...
NC State to host fifth annual AIM-Bio Symposium
The fifth annual AIM-Bio Biopharmaceutical Manufacturing Symposium is scheduled for Nov. 18–19, 2024, at NC State University. AIM-Bio researchers, educators, External Advisory Board members and...
Chancellor’s Innovation Fund supports innovative new technology
“MembraneWorks: Membrane Chromatography Systems for Purification of Biologics,” a new NC State research program, is one of six projects selected for funding by the Chancellor’s...